Low-grade inflammation as a risk factor for cardiovascular events and all-cause mortality in patients with type 2 diabetes

Low-grade inflammation as a risk factor for cardiovascular events and all-cause mortality in patients with type 2 diabetes

Abstract Background Type 2 diabetes is a condition associated with a state of low-grade inflammation caused by adipose tissue dysfunction and insulin resistance. High sensitive-CRP (hs-CRP) is a marker for systemic low-grade inflammation and higher plasma levels have been associated with cardiovascu...

Full description

Bibliographic Details
Main Authors:	Shahnam Sharif, Y. Van der Graaf, M. J. Cramer, L. J. Kapelle, G. J. de Borst, Frank L. J. Visseren, Jan Westerink, the SMART study group
Format:	Article
Language:	English
Published:	BMC 2021-11-01
Series:	Cardiovascular Diabetology
Online Access:	https://doi.org/10.1186/s12933-021-01409-0

Similar Items

Screen-detected abnormal ankle brachial index: A risk indicator for future cardiovascular morbidity and mortality in patients with manifest cardiovascular disease.
by: Vivianne L Jagt, et al.
Published: (2022-01-01)

The relation between urinary sodium and potassium excretion and risk of cardiovascular events and mortality in patients with cardiovascular disease.
by: Eline H Groenland, et al.
Published: (2022-01-01)

The relation between urinary sodium and potassium excretion and risk of cardiovascular events and mortality in patients with cardiovascular disease
by: Eline H. Groenland, et al.
Published: (2022-01-01)

Pioglitazone and the secondary prevention of cardiovascular disease. A meta-analysis of randomized-controlled trials
by: Marit de Jong, et al.
Published: (2017-10-01)

Estimated Life Expectancy Without Recurrent Cardiovascular Events in Patients With Vascular Disease: The SMART‐REACH Model
by: Lotte Kaasenbrood, et al.
Published: (2018-08-01)

Modifiable risk factors in adults with and without prior cardiovascular disease: findings from the Indonesian National Basic Health Research
by: Dian Sidik Arsyad, et al.
Published: (2022-04-01)

Effect of adding bezafibrate to standard lipid-lowering therapy on post-fat load lipid levels in patients with familial dysbetalipoproteinemia. A randomized placebo-controlled crossover trial
by: Charlotte Koopal, et al.
Published: (2017-11-01)

Risk Factor Clusters and Cardiovascular Disease in High-Risk Patients: The UCC-SMART Study
by: Emily I. Holthuis, et al.
Published: (2021-12-01)

Relationship between classic vascular risk factors and cumulative recurrent cardiovascular event burden in patients with clinically manifest vascular disease: results from the UCC-SMART prospective cohort study
by: Yvo M Smulders, et al.
Published: (2021-03-01)

The readiness of public primary health care (PUSKESMAS) for cardiovascular services in Makasar city, Indonesia
by: Dian Sidik Arsyad, et al.
Published: (2022-09-01)

Rs964184 (APOA5-A4-C3-A1) is related to elevated plasma triglyceride levels, but not to an increased risk for vascular events in patients with clinically manifest vascular disease.
by: Anton P van de Woestijne, et al.
Published: (2014-01-01)

Chronic kidney disease and atrial fibrillation: A dangerous combination.
by: Gurbey Ocak, et al.
Published: (2022-01-01)

Time cannot heal all wounds: Wealth trajectories of divorcees and the married
by: Kapelle, N
Published: (2022)

Insulin resistance increases the occurrence of new cardiovascular events in patients with manifest arterial disease without known diabetes. The SMART study
by: Verhagen Sandra N, et al.
Published: (2011-11-01)

Pharmacological and non-pharmacological interventions to influence adipose tissue function
by: Visseren Frank LJ, et al.
Published: (2011-01-01)

Multifocal cardiovascular calcification in patients with established cardiovascular disease; prevalence, risk factors, and relation with recurrent cardiovascular disease
by: Cilie C. van 't Klooster, et al.
Published: (2020-04-01)

Novel Biomarkers to Improve the Prediction of Cardiovascular Event Risk in Type 2 Diabetes Mellitus
by: Joep van der Leeuw, et al.
Published: (2016-06-01)

Prediction of cardiovascular events by using non-vascular findings on routine chest CT.
by: Pim A de Jong, et al.
Published: (2011-01-01)

Impact of a Patient’s Baseline Risk on the Relative Benefit and Harm of a Preventive Treatment Strategy: Applying Trial Results in Clinical Decision Making
by: Tamar I. de Vries, et al.
Published: (2022-01-01)

Development of a clinical decision tool to reduce diagnostic testing for primary aldosteronism in patients with difficult-to-control hypertension
by: Monique E. A. M. van Kleef, et al.
Published: (2020-04-01)

Impact of diabesity phenotype on cardiovascular diseases, major cardiovascular events and all-cause mortality
by: Kamran Mehrabani-Zeinabad, et al.
Published: (2023-07-01)

Sodium-based paracetamol: impact on blood pressure, cardiovascular events, and all-cause mortality
by: Rao, S, et al.
Published: (2023)

All-cause mortality and cardiovascular events in a Spanish nonagenarian cohort according to type 2 diabetes mellitus status and established cardiovascular disease
by: MA Salinero-Fort, et al.
Published: (2022-03-01)

Serum IL8 is not associated with cardiovascular events but with all-cause mortality
by: Ilais Moreno Velásquez, et al.
Published: (2019-02-01)

NT-proBNP for risk prediction of cardiovascular events and all-cause mortality: The getABI-study
by: Henrik Rudolf, et al.
Published: (2020-08-01)

Association of body mass index and waist circumference with long-term mortality risk in 10,370 coronary patients and potential modification by lifestyle and health determinants.
by: Esther Cruijsen, et al.
Published: (2024-01-01)

Relationship Between Serum Indirect Bilirubin Levels and Cardiovascular Events and All-Cause Mortality in Maintenance Hemodialysis Patients
by: Chen Y, et al.
Published: (2022-12-01)

All-cause mortality and serious cardiovascular events in people with hip and knee osteoarthritis: a population based cohort study.
by: Gillian A Hawker, et al.
Published: (2014-01-01)

Novel aspects of chemokine receptor signalling in cardiovascular inflammation
by: Patel, J, et al.
Published: (2018)

Cardiovascular risk factor treatment targets and renal complications in high risk vascular patients: a cohort study
by: Visseren Frank LJ, et al.
Published: (2011-07-01)

Prediction model for cardiovascular events or all-cause mortality in incident dialysis patients.
by: Daijo Inaguma, et al.
Published: (2019-01-01)

Associations of polyneuropathy with risk of all‐cause and cardiovascular mortality, cardiovascular disease events stratified by diabetes status
by: Kyuho Kim, et al.
Published: (2023-11-01)

Systemic Immune-Inflammation Index Was Significantly Associated with All-Cause and Cardiovascular-Specific Mortalities in Patients Receiving Peritoneal Dialysis
by: Li G, et al.
Published: (2023-08-01)

Seropositivity to cytomegalovirus, inflammation, all-cause and cardiovascular disease-related mortality in the United States.
by: Amanda M Simanek, et al.
Published: (2011-02-01)

Serum free thiols predict cardiovascular events and all-cause mortality in the general population: a prospective cohort study
by: Amaal E. Abdulle, et al.
Published: (2020-05-01)

Physical Activity and Characteristics of the Carotid Artery Wall in High‐Risk Patients—The SMART (Second Manifestations of Arterial Disease) Study
by: H. Myrthe Boss, et al.
Published: (2017-07-01)

The prognostic value of the systemic immunity–inflammation index for cardiovascular and all‐cause mortality in cardiovascular disease patients with diabetes or prediabetes
by: Zhengyi Long, et al.
Published: (2025-03-01)

Prediction of Lifetime and 10-Year Risk of Cancer in Individual Patients With Established Cardiovascular Disease
by: Cilie C. van ’t Klooster, MD, et al.
Published: (2020-09-01)

Inflammation-Dependent Association of Lipoprotein (a) with Cardiovascular and Cancer Mortality
by: Zhang Y, et al.
Published: (2024-01-01)

The relationship between walking speed and changes in cardiovascular risk factors during a 12-day walking tour to Santiago de Compostela: a cohort study
by: Frank L J Visseren, et al.
Published: (2012-05-01)